Ginkgo Bioworks
Ginkgo Bioworks
Ginkgo Bioworks Lands $222M for Biosecurity Innovation!
🌟 Ginkgo Bioworks lands a $22.2M contract! 🧬 Enhancing monoclonal antibody production for filoviruses like Ebola. 🤝 Innovation for biosecurity! 💪
Ginkgo Bioworks: Is Nature the Key to Survival?
🌱 Ginkgo Bioworks faces a crisis! 🌍 Embrace evolution-driven solutions and innovative QTL technology for sustainable breakthroughs in drug development. 🔬🧬
Revolutionizing mRNA: A Breakthrough in Biologics!
🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡
Ginkgo Bioworks’ Stock Plummets with Massive Layoffs
📢 Ginkgo Bioworks' stock fell 26 after layoffs, but rebounded. ARK selloff also affected the stock. 💰💼💸📈
Moderna Teams Up for Biotech Breakthroughs and Rare Diseases
🌱 Moderna teams up with Form Bio and Ginkgo Bioworks to advance biotechnology roots, focusing on mRNA therapeutics and vaccines. 🧬🌍 Researchers also prioritize rare autoimmune diseases for better patient outcomes.
